Summary.-Carcinoembryonic antigen-like substances in the urine of patients with bladder carcinoma and of healthy male subjects occur in a wide range of average molecular sizes. Some of these substances are glycoproteins giving reactions of antigenic identity with carcinoembryonic antigen (CEA) derived from colorectal carcinoma and occur in aggregation with proteins showing antigen specificities of albumin, haptoglobin and the heavy chains of immunoglobulins G, A and M. Recoveries of CEA-like activities, following Sepharose 4B chromatography of urinary materials of molecular size > 3 x 104, varied from 40 to 1530%. Treatment with 1 mol/l HC104 caused an apparent solubilization of 85% of the CEA-like activity of such materials from the urine of a patient with bladder carcinoma and raised the specific CEA-like activity of the solubilized product to 379O% of that of the untreated materials.
Summary.-Carcinoembryonic antigen-like substances in the urine of patients with bladder carcinoma and of healthy male subjects occur in a wide range of average molecular sizes. Some of these substances are glycoproteins giving reactions of antigenic identity with carcinoembryonic antigen (CEA) derived from colorectal carcinoma and occur in aggregation with proteins showing antigen specificities of albumin, haptoglobin and the heavy chains of immunoglobulins G, A and M. Recoveries of CEA-like activities, following Sepharose 4B chromatography of urinary materials of molecular size > 3 x 104, varied from 40 to 1530%. Treatment with 1 mol/l HC104 caused an apparent solubilization of 85% of the CEA-like activity of such materials from the urine of a patient with bladder carcinoma and raised the specific CEA-like activity of the solubilized product to 379O% of that of the untreated materials.
THE oncofoetal relationship between an antigen first thought to be specific for carcinomata of the digestive system and foetal gut was first described by Gold and Freedman (1965) . This carcinoembryonic antigen (CEA) or other antigenically related substances, were later shown to occur in comparatively low concentrations in a wide variety of normal tissues and in generally higher concentrations in tissues associated with increased cellular turnover as a result of injury or disease, especially in advanced and metastatic tumours and in a variety of non-neoplastic inflammatory or regenerative disorders (Martin and Martin, 1970; Freed and Taylor, 1972; Laurence et al., 1972; Reynoso et al., 1972; Hall et al., 1972; Nery, Barsoum and Bullman, 1973) . In particular, such substances have been detected by radioimmunoassay in the urines of patients bearing urothelial carcinomata (Hall et al., 1972) . Some of the properties of the urinary component having a mean molecular size (i.e. 2 x 105, Krupey, Gold and Freedman, 1968) similar to that of CEA derived from colorectal carcinomata have been described (Nery et al., 1974) . We now describe the isolation and some properties of macromolecular aggregates containing CEA-like activity from the urines of patients with bladder (urothelial) carcinoma and, in lesser amounts, of normal subjects. MATERIALS (Davis, 1964) . The sample (20-30 jig) was dissolved in the appropriate electrophoresis buffer (10-15 ,l) containing, where appropriate, dissolved urea (50-75 ,umol Nery et al. (1974) .
RESULTS
Preliminary preparation ofurinaryfractions (a) Urines clarified by centrifugation at 2200 g at 4°C for 30 min were ultrafiltered through a PM-30 membrane in the Amicon ultrafiltration apparatus with stirring at 4°C. For each litre of urine, the material retained on the filter was washed with distilled water (2 x 100 ml) and dissolved in distilled water (25 ml). The resulting solution was dialysed in Visking tubing at 4°C for 24 h against one change of distilled water and freeze dried. This gave approximately 0-08-041 g and 0-85-1-1 g of freeze dried product/I of pooled urine (urine 6; Table) from healthy male subjects and of urine (urines 1-5, Table) from individual patients with bladder carcinoma respectively. The products showed 50 and 9-95 ng of antigenic activity/mg of residue, as determined by radioimmunoassay (Table, columns Sa of urine 6 and of urines 1-5, respectively).
(b) The aqueous solution (750 ml) ofthe material retained on the PM-30 membrane from a sample (30 litre) of urine 5 (Table) from a patient with bladder carcinoma contained 25-65 mg of antigenic activity as determined by radioimmunoassay. A sample (250 ml) of the solution was (i) dialysed and freeze dried as in (a) to give a product (9 g) showing 950 ng of antigenic activity/mg of residue. At 4°C, the remainder of the solution was (ii) treated with an equal volume of 2 mol/l-HCl04, stirred for 30 min, centrifuged at 2200 g for 30 min and the clear supernatant dialysed in Visking tubing for 3 days against 6 changes of distilled water and freeze dried. The product (4.04 g) showed 3600 ng of antigenic activity/mg ofresidue. This indicated that the acid extraction procedure solubilized approximately 85% of the antigenic activity but increased the specific (w/w) antigenic activity of the solubilized product to 379% of that of the freeze dried product obtained from the same urine as described in (b) (i).
(c) Urine, collected by catheterization of the bladder of a female patient with bladder carcinoma, was treated with sodium azide to a final concentration of 0-02% (w/v) and divided into 2 equal portions. Corresponding portions were combined as collected and stored (i) at 4°C for approximately one week during collection or (ii) frozen at -20°C for a total period of approximately one month during, and after, collection. Sample (i) (6 1) was centrifuged at 2200 g at 4°C for 30 min and the supernatant solution concentrated to approximately 100 ml by ultrafiltration through a PM-30 membrane, diluted with distilled water (3 X 100 ml) and the volume of the diluted solution reduced to approximately 45 ml after each dilution step. The final solution was diluted with 0-1 mol/l phosphate buffered saline (pH 5-8, 50 ml), the total volume adjusted to 100 ml with distilled water and the mixture centrifuged as before. The supernatant solution, as determined by radioimmunoassay, contained 51 ng of antigenic activity/ml of solution, i.e. a total antigenic activity of 5-1 mg. Sample (ii) (6 1) was processed as in (a) above; the freeze dried product (5-5 g), as determined by radioimmunoassay, contained 950 ng of antigenic activity/mg of residue, i.e. a total antigenic activity of 5-2 mg or approximately 102 % of the total antigenic activity recovered by procedure (c) (i). This indicated that freezing and thawing of the urine did not significantly alter the antigenic activity of the same urine not subjected to such processes.
Sepharose 4B chromatography A sample (4-6 g) of each freeze dried product obtained as described in (a), (b) and (c) (ii) above, dissolved in phosphate buffered saline (pH 5-8) at a concentration of 10% (w/v), was centrifuged on a bench centrifiuge to remove small amounts of insoluble materials. Each resulting solution, the centrifuged final solution described in (c) (i) above and carcinoembryonic antigen (5 mg), obtained as a Sephadex G200 fraction from colorectal carcinoma (Krupey et al., 1968) and dissolved in the same buffer (10 ml) were severally chromatographed on a column of Sepharose 4B. Representative elution profiles showing the main features of the results are shown in Fig. 1 , as follows: (1) There was a wide distribution of antigenic activity, according to molecular size, in all the samples. Table) of the elution profiles: one (UCEA-3, peak A) was excluided by the gel and the other (UCEA-1, peak C) eluted almost coincidentally with CEA derived from colorectal carcinoma (curve 5). The single main peak of activity shown by urine 4 was of size intermediate between that of UCEA-l and of UCEA-3. (3) Perchloric acid treatment of the fraction of urine 5 (urine 5a, Table) Fig. 1 ) of urine 5a (Table) , was dissolved in phosphate buffered saline (pH 5f8; 5 ml) and chromatographed on a column of Sepharose 2B. Radioimmunoassay of effluent fractions showed (Fig. 2) minor peak of lower nmean molecular size similar to that given when purified (Krupey et al., 1968 ) CEA (2 mg) derived from colorectal carcinoma was similarly chromatographed.
Polyacrylamide gel electrophoresis
The following samples were used: (1) UCEA-1 (20 ,ug) purified by successive gel filtration on Sepharose 4B and Sephadex G200 followed by Cellogel block electrophoresis (Nery et al., 1974) ; (2) CEA (20 jag) derived from colorectal carcinoma and obtained as a Sephadex G200 fraction (Krupey et al., 1968) and (3) UCEA-3 (40 ,ug) obtained after dialysis and freeze drying of the Sepharose 4B fraction A (Fig. 1 ) of urine 5 (Table) . Duplicate samples were subjected to electrophoresis in 150% (w/v) polyacrylamide gels in borate buffer at 3 mA/gel for 7 h in the absence (gels 1-3 respectively) and pr.-sence (gels 4-6 respectively) of 5 mol/l urea. The gels were stained for glycoproteins by the periodate-Schiff procedure of Zacharius et al. (1969) and for proteins with Coomassie Brilliant Blue. The results (Fig. 3) showed apparently identical protein and glycoprotein bands for UCEA-1 (gel 1) and CEA (gel 2) having an electrophoretic mobility of 0 6-0 7 mm/h per mA, unchanged in the presence of urea (gels 4 and 5 respectively). By contrast, UCEA-3 penetrated the gel poorly in the absence of urea (gel 3) but released, in its presence (gel 6), a diffuse glycoprotein band having a mean electrophoretic mobility similar to that of the other 2 antigens.
Immunoelectrophoresis on ('elloqel strips
Samples of CEA (30 ,ug) and of Sepharose 4B sub-fractions A and C (Fig. 1 given by all the samples; UCEA-3 (Sepharose 4B sub-fraction A) also give a slower, less well defined precipitin line (Fig. 4) . The other electrophoretograms, stained for glycoprotein by the periodate-Schiff procedure of Bodman (1 960 (w/v) gels at 3 mA/gel for 7 h in the absence (gels 1-3) and presence (ge!s 4-6) of urea. Gels I and 4, UCEA-1 (purified Sepharose 4B sub-fraction C, Fig. 1 ) and gels 3 and C, UCEA-3 (Sepharose 4B sub-fraction A, Fig. 1 ) from the urine of a patient with bladder carciinoma; gels 2 aI(1 5, CEA dlerived from colorectal carcinoma. (Table) and lane 2 contained CEA derived from colorectal carcinoma. Immunodiffusion was against undiluted monospecific goat anti-CEA antiserum.
proteins with Coomassie Brilliant Blue, showed the presence of a major band, stained with both reagents, which was coincident with the centre of the common precipitin arc and had a mean electrophoretic mobility of 50-52 mm/h per mA. Other unidentified bands were also revealed for the urinary fractions.
Identification by immunodiffusion of some component8 of the UCEA-3 complex Petri dishes were coated to a depth of 2 mm with a 1-5% (w/v) solution of agarose in barbitone buffered saline. The peripheral wells (Fig. 5) contained: (1) UCEA-1 (2 mg) obtained from the urine of a patient with bladder carcinoma and purified finally by Cellogel block electrophoresis as described by Nery et al. ( 1974) ; (2) undiluted monospecific goat anti-CEA antiserum (30 ,ld) ; (3) CEA (20 ,tg) derived from colorectal carcinoma and purified finally on Sephadex G200 as described by Krupey et al. (1968) ; and 4-10, undiluted goat anti-human serum or goat anti-human serum components (20 ll) as follows: (4) anti-IgG (y-chain monospecific); (5) anti-whole human serum; (6) anti-IgA (a-chain monospecific); (7) anti-IgD (8-chain monospecific); (8) anti-IgM (,u-chain monospecific); (9) anti-albumin and (10) antihaptoglobin. The centre wells (Fig. 5a ) contained UCEA-3 (4 mg), obtained after dialysis and freeze-drying of combined Sepharose 4B fraction A (Fig. 1 ) of urine 5 (Table) ; the centre wells (Fig. 5b) contained the corresponding dialysed and freeze dried fraction of the combined urines (urine 6, (1) UCEA-1; (2) undiluted monospecific goat anti-CEA antiserum; (3) CEA derived from colorectal carcinoma, and (4-10) undiluted goat anti-whole human serum or undiluted goat anti-human serum components, as follows: (4) anti-IgG (y-chain monospecific); (5) anti-whole; (6) anti-IgA (a-chain monospecific); (7) anti-IgD (6-chain monospecific); (8) anti-IgM (1t-chain monospecific); (9) anti-albumin and 10, anti-haptoglobin. The centre wells contained Sepharose 4B sub-fraction A of urine (urine 5, Table) from a patient with bladder carcinoma (Fig. 5a ) or of urine (urine 6) from healthy male subjects (Fig. 5b) .
(50-100 jdl). After immunodiffusion in a moist chamber at room temperature for 72 h, the immunograms were washed in several changes of the same buffer by periodical agitation at room temperature for 24 h and photographed. The results ( Fig. 5 and Table) show the presence of components of the UCEA-3 complex giving reactions of antigenic identity with CEA derived from colorectal carcinoma and others having antigenic specificities characteristic of albumin, hiptoglobin and the heavy chains of IgG and IgA. The other UCEA-3 complexes (Fractions A, Fig. 1 , of urines 1-3, Table) also showed the presence of these components in varying amounts; in addition, those from urines 1 and 3 showed the presence of a component having antigenic specificity characteristic of the heavy chain of IgM. Fraction A (Fig. 1 ) of the perchloric acid soluble components of urine 5 (Table) showed the presence of substances bearing the IgG and IgM, but not the other specificities. The corresponding complex from fraction A (Fig. 1) of urine (urine 6, Table) from healthy male subjects showed components having the albumin and IgG but not the haptoglobin, IgA or IgM specificities detectable under the conditions described (Fig. 5b) . The results are summarized in the Table. DISCUSSION The present study describes 3 apparently characteristic properties of urinary substances which cross-react during radioimmunoassay with CEA derived from colorectal carcinoma. These properties are heterogeneity in molecular size, a pronounced tendency to occur in large multi-component aggregates and low specific activity, i.e. weight equivalent antigenic activity per unit weight of the substance.
Heterogeneity in molecular size was evident from the wide distribution of antigenic activity in Sepharose 4B fractions of all samples of urines investigated (Fig. 1 and Table) . Conceivably, this heterogeneity might have resulted from interactions of a single CEA-like glycoprotein (Component C, Fig. 1 ) having a mean molecular size approximately similar to that (2 x 105; Krupey et al., 1968) of CEA derived from colorectal carcinoma; the larger (A and B, Fig. 1 ) or smaller (D) components would then have arisen from aggregation or hydrolysis by urinary hydrolases, respectively, of component C. This appears unlikely for several reasons: (a) A Sephadex G200 fraction of component C (UCEA-1) derived from the urine of a patient with bladder carcinoma and a similar fraction of CEA derived from colorectal carcinoma were not appreciably degraded after incubation at 37°C for 16 h of solutions of the antigens in urine from healthy subjects or from patients with bladder carcinoma (James, Neville and Nery, unpublished) . (b) The specific activities ((b), Table) of components S and A-D (Table) of the various urines showed wide variations and no consistent pattern emerged. (c) The highest specific activity (0.51%) occurred in component C of a perchloric acid soluble fraction (urine 5a) of urine from a patient with bladder carcinoma. Further purification of this component by successive gel filtration on Sephadex G200 and Cellogel block electrophoresis gave a final product having a specific activity of 30 (Nery et al., 1974) . By contrast, the corresponding Sepharose 4B and Sephadex G200 fractions of perchloric acid extracts of colorectal carcinoma contained specific activities of 40-80% and 60-100% respectively (Krupey et al., 1968; Coligan et al., 1973; Turberville et al., 1973) .
Some urinary CEA-like substances occurred in large multi-component aggregates. The aggregations were probably neither due to contamination with cervical secretions nor induced by experimental procedures involving freezing and thawing of the urines, followed by freeze drying of the various dialysed fractions. Urine collected by catheterization of the bladder ofa patient with bladder carcinoma showed similar distributions of antigenic activity during Sepharose 4B chromatography whether such procedures were employed or eliminated. Sepharose 4B fractions ( Fig. 1 and Table) , showing mean molecular weights of over 20 million (Fraction A) and intermediate (Fraction B) between this and 2 x 105 (i.e. the mean molecular weight of fractions C and of CEA derived from colorectal carcinoma) released components which were qualitatively indistinguishable from CEA derived from colorectal carcinoma in several respects: (a) Such components were released (i) during perchloric acid extraction of urine 5 (compare curves 1 and 2 of Fig. 5 , obtained before and after extraction, respectively) and during gel filtration on Sepharose 2B (Fig. 2) of the perchloric acid soluble Sepharose 4B fraction A of the same urine, indicating similarity in molecular size and (ii) during electrophoresis in polyacrylamide gels (Fig. 3) and immunoelectrophoresis on Cellogel (Fig. 4) (Fig. 3 and 4) . (d) Treatment of Sepharose 4B fraction A (Fig. 1 ) of urine 5 (Table) with 5 mol/l urea caused disaggregation releasing at least 2 components bearing antigenic similarities to CEA derived from colorectal carcinoma (Fig. 4) . Urinary components showing reactions of partial antigenic identity with CEA have also been detected (Darcy, personal communication, and Nery et al., 1974) . Sepharose 4B fractions A and B also contained substances (in variable amounts and occurrence) showing antigenic specicities of albumin, haptoglobin and the heavy chains of immunoglobulins G, A and M (Fig. 5) . The presence of the heavy chain IgM specificity (Nery and James, unpublished) in preparations of UCEA-1 (mean mol. wt 2 x 105) may thus be due to the separated ,u-chains and not to the intact IgM molecule (mol. wt. 9 x 105). Further, perchloric acid solubilized only part (7900) of the CEA-like activity giving a macromolecular aggregate (Fraction A, Fig. 1 of urine 5, Table) containing immunoglobulin specificities (Table) ; it is thus possible that some of the immunoglobulins or their component heavy chains are attached to CEA-like components of varying carbohydrate composition by covalent, e.g. disulphide, bonds not disrupted by acid treatment and resulting in precipitation of the CEA-like components of low carbohydrate composition.
The low specific activity (columns (b)
of Sepharose 4B fractions S and A-D, Table) was not significantly different in urine (urine 6) of healthy male subjects and in urine (urines 1-5) of cancer patients. The higher antigenic activity found in the latter urines (Hall et al., 1972) might thus have resulted in part from the higher concentration (approximately 1 g/l and 0-1 g/l of urine from the cancer patients and normal subjects respectively) of urinary components containing CEA-like activity and having an approximate molecular weight greater than 3 x 104.
Since an approximately ten-fold difference in urinary titre between the cancer patients and healthy subjects has not been observed (Table, (Nery et al., 1974) . Some of these components might have been freed from aggregation and lost during the extensive dialysis of the Sepharose 4B fractions. Comparison of these fractions of urine 4 shows the highest proportion of antigenic activity in Fraction B before (curve 4 of Fig. 1 ), but the lowest after (0.9 ,ag or 3.6% of the total eluted activity) the fractions were dialysed. The dialysed fractions also showed the highest relative proportions of CEA-like components of molecular sizes greater (Ac + BC/CC, Table) than that of fraction C, with the bulk (80%) of the non-dialysable activity now occurring in the fraction (Fraction A) of greatest molecular size. This and other studies (Martin and Martin, 1970; Freed and Taylor, 1972; Reynoso et al., 1972; Nery et al., 1973) showing the presence of substances giving positive values during radioimmunoassays for CEA in both normal and diseased states indicate that such substances may represent a family of antigenically related molecules. These substances are generally secreted in greater amounts during injury and disease and may differ from one another by, as yet undetermined, structural modifications of normal tissue components as a result of impaired cellular metabolism.
